Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jon T Giles

Showing results (1-10 of 155) with videos related to

Pageof 16
Sort By:
Clinical Therapeutics|June 15, 2019
Extra-articular Manifestations and Comorbidity in Rheumatoid Arthritis: Potential Impact of Pre-Rheumatoid Arthritis PreventionJon T Giles
Current Opinion in Rheumatology|February 22, 2018
Getting personal: towards individualized management of rheumatoid arthritisJon T Giles
Current Rheumatology Reports|April 2, 2016
Rheumatoid Arthritis Pharmacotherapies: Do They Have Anti-Atherosclerotic Activity?Jon T Giles
The Journal of Rheumatology|February 3, 2019
On Needles and Haystacks: The Perils of Cardiovascular Risk Screening in Rheumatoid ArthritisJon T Giles
The Journal of Rheumatology|September 17, 2014
Adipokine mediators of inflammation and cardiometabolic comorbidity in rheumatoid arthritis: is there a master adipokine?Jon T Giles
Best Practice & Research. Clinical Rheumatology|December 25, 2015
Cardiovascular disease in rheumatoid arthritis: Current perspectives on assessing and mitigating risk in clinical practiceJon T Giles
Arthritis & Rheumatology (Hoboken, N.J.)|May 29, 2015
Reply: To PMID 25504899Jon T Giles, Joan M Bathon
Journal of Intensive Care Medicine|November 4, 2004
Serious infections associated with anticytokine therapies in the rheumatic diseasesJon T Giles, Joan M Bathon
Current Allergy and Asthma Reports|December 16, 2014
Inflammation, adiposity, and atherogenic dyslipidemia in rheumatoid arthritis: is there a paradoxical relationship?Ayse Bag-Ozbek, Jon T Giles
Current Opinion in Rheumatology|June 6, 2008
Do antitumor necrosis factor agents increase the risk of postoperative orthopedic infections?Dimitrios A Pappas, Jon T Giles
Pageof 16

Showing results (1-10 of 155) with videos related to

Sort By:
Pageof 16
Clinical Therapeutics|June 15, 2019
Extra-articular Manifestations and Comorbidity in Rheumatoid Arthritis: Potential Impact of Pre-Rheumatoid Arthritis PreventionJon T Giles
Current Opinion in Rheumatology|February 22, 2018
Getting personal: towards individualized management of rheumatoid arthritisJon T Giles
Current Rheumatology Reports|April 2, 2016
Rheumatoid Arthritis Pharmacotherapies: Do They Have Anti-Atherosclerotic Activity?Jon T Giles
The Journal of Rheumatology|February 3, 2019
On Needles and Haystacks: The Perils of Cardiovascular Risk Screening in Rheumatoid ArthritisJon T Giles
The Journal of Rheumatology|September 17, 2014
Adipokine mediators of inflammation and cardiometabolic comorbidity in rheumatoid arthritis: is there a master adipokine?Jon T Giles
Best Practice & Research. Clinical Rheumatology|December 25, 2015
Cardiovascular disease in rheumatoid arthritis: Current perspectives on assessing and mitigating risk in clinical practiceJon T Giles
Arthritis & Rheumatology (Hoboken, N.J.)|May 29, 2015
Reply: To PMID 25504899Jon T Giles, Joan M Bathon
Journal of Intensive Care Medicine|November 4, 2004
Serious infections associated with anticytokine therapies in the rheumatic diseasesJon T Giles, Joan M Bathon
Current Allergy and Asthma Reports|December 16, 2014
Inflammation, adiposity, and atherogenic dyslipidemia in rheumatoid arthritis: is there a paradoxical relationship?Ayse Bag-Ozbek, Jon T Giles
Current Opinion in Rheumatology|June 6, 2008
Do antitumor necrosis factor agents increase the risk of postoperative orthopedic infections?Dimitrios A Pappas, Jon T Giles
Pageof 16